查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1438170

2030 年醫療植入市場預測：按產品、材料、最終用戶和地區分類的全球分析

Medical Implant Market Forecasts to 2030 - Global Analysis By Product, Material, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球醫療植入市場規模將達到985億美元，預計2030年將達到1,825億美元，預測期內複合年成長率為9.2%。

醫療植入市場旨在透過手術植入體內，用於替換或支撐受損的生物結構、增強身體功能和監測健康狀況等目的。植入式醫療設備有多種用途，包括恢復器官功能、治療慢性疾病和提高運動表現。此外，人工電子耳可以幫助恢復聽力，胰島素幫浦可以幫助控制糖尿病。這些設備不僅有助於延長和改善生命，還可以幫助患者恢復功能。

根據美國癌症協會2023年發布的報告，2022年美國女性將診斷出297,790例新的侵襲性乳癌病例，而馬蘇的新病例為287,850例。根據美學協會統計，2021年共有147,684例乳房植入移除/置換手術，佔手術收入的6%。

醫療支出不斷成長

隨著各國投入大量財政資源來加強醫療基礎設施和服務，先進醫療技術（包括植入設備）的取得和採用也不斷增加。隨著對提供優質醫療保健的重視，不斷增加的醫療保健成本意味著對醫療干預措施進步的承諾，特別是植入式設備，它為各種醫療狀況提供先進、有效且常常危及生命的治療方法，已成為重要組成部分。

高成本

複雜的研究、開發和製造流程，加上嚴格的監管核准的需要，導致製造成本高昂。因此，這些成本通常會轉嫁給醫療保健提供者，進而轉嫁給患者，使植入式解決方案在經濟上造成負擔。這些高昂的經濟障礙可能會限制醫療植入的取得，並阻礙患者選擇這些先進的治療方法，特別是在醫療保健預算有限的地區。然而，成本因素加劇了現有的醫療保健差距，因為負擔不起的患者很難獲得尖端的植入式醫療設備。

患者對植入式解決方案的偏好

由於生活品質提高和長期治療結果等明顯的好處，患者擴大選擇植入式設備而不是傳統治療方法。無論是用於整形外科疾病的關節假體還是用於慢性疼痛管理的神經刺激設備，患者都欣賞許多植入提供的增強功能和活動性的潛力。此外，對美容植入（例如乳房植入和牙科修補）的接受度不斷提高，反映出社會更廣泛地轉向接受有助於整體福祉和自尊的醫療干預措施。

併發症和失敗風險

患者和醫療保健提供者通常對與植入手術相關的潛在不良後果（從儀器故障到術後併發症）持謹慎態度。對醫療植入安全性和有效性的擔憂導致患者和醫療保健專業人員猶豫不決，阻礙了這些技術的普及。然而，設備故障或併發症的案例不僅會傷害患者，還會引發法律和監管審查，進一步減緩市場發展。

COVID-19 的影響：

全球健康危機造成的直接損害導致擇期手術的延遲和取消，影響了對各種醫療植入的需求。醫院和醫療保健機構已將重點和資源轉移到管理 COVID-19 病例激增上，從而轉移了對非緊急程序的注意力。然而，供應鏈中斷、流動限制和製造放緩也阻礙了醫療植入的生產和分銷。

預計整形外科植入領域在預測期內將是最大的

由於骨關節炎、骨折和肌肉骨骼疾病等整形外科疾病的發病率上升以及全球人口老化，預計整形外科植入領域將在預測期內佔據最大佔有率。隨著人們尋求增加活動能力和提高生活品質，對整形外科植入（包括人工關節和脊椎移植）的需求正在迅速增加。此外，微創手術的成長趨勢進一步推動了對整形外科植入的需求。這是因為這些手術通常恢復時間較短且術後併發症較少。

預計門診手術中心產業在預測期內將呈現最高的複合年成長率。

門診手術中心透過提供比傳統醫院更具成本效益、高效且以患者為中心的替代方案，正在改變醫療保健服務。與傳統醫院相比，病人越來越喜歡ASC，因為它方便、手術時間更短、感染風險更低。強調個人化和專業護理的醫學進步進一步推動了 ASC 對醫療植入的需求。

比最大的地區

先進的醫療基礎設施和快速老化的人口相結合，使北美在整個估計期間佔據了最大的市場佔有率。該國完善的醫療保健體系，加上有利的報銷環境，支持尖端植入技術的採用。此外，醫療提供者、製造商和監管機構之間的策略合作夥伴關係促進了高效的核准流程，並確保新的和改進的醫療植入及時進入市場。

複合年成長率最高的地區：

預計亞太地區在整個預測期內將實現獲利成長。經濟的快速發展和對技術進步的日益關注正在促進該地區的崛起。特別是中階人口的增加和醫療意識的提高，導致各個治療領域對醫療植入的需求增加。中國、印度和日本等國家的監管機構正在積極努力簡化核准流程，以確保創新且安全的醫療植入有效地推向市場。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球醫療植入市場：依產品

  • 整形外科植入
    • 髖關節整形外科器
    • 關節重組
    • 膝關節整形外科器
    • 脊椎整形外科器械
    • 其他
  • 心血管植入
    • 結構性心臟植入
    • 起搏器
    • 其他
  • 眼科植入
    • 青光眼植入
    • 人工水晶體
    • 其他
  • 隆乳手術
  • 人工植牙
  • 其他

第6章全球醫療植入市場：依材料分類

  • 陶瓷生物材料
  • 天然生物材料
  • 高分子生物材料
  • 金屬生物材料
  • 其他

第7章全球醫療植入市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 其他

第8章全球醫療植入市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • 3M Company
  • Abbott Laboratories
  • Biotronik, Inc
  • Boston Scientific Corporation
  • Institut Straumann AG
  • Johnson & Johnson Medical GmbH
  • Livanova Plc
  • Medtronic plc
  • Novartis International AG
  • Smith & Nephew plc
  • Stryker Corporation
Product Code: SMRC25139

According to Stratistics MRC, the Global Medical Implant Market is accounted for $98.5 billion in 2023 and is expected to reach $182.5 billion by 2030 growing at a CAGR of 9.2% during the forecast period. The medical implant market is designed to be surgically placed within the body to replace or support damaged biological structures, enhance bodily functions, or monitor health conditions. Implantable medical devices serve diverse purposes, such as restoring organ function, managing chronic diseases, and improving mobility. Additionally, cochlear implants help restore hearing, while insulin pumps aid in diabetes management. These devices not only contribute to extending and improving lives but also enable patients to regain functionality.

According to the report published by the American Cancer Society in 2023, 297,790 new cases of invasive breast cancer will be diagnosed in women in the United States compared to 287,850 new breast cancer cases in 2022. According to the Aesthetic Society Statistics, in 2021, there were 147,684 breast implant removal/replacement procedures constituting 6% of surgical revenue.

Market Dynamics:

Driver:

Growing healthcare expenditures

As nations allocate substantial financial resources to enhance healthcare infrastructure and services, there is a parallel increase in the accessibility and adoption of advanced medical technologies, including implantable devices. With a growing emphasis on providing high-quality healthcare, the rise in healthcare expenditures signifies a commitment to advancing medical interventions, and implantable devices, in particular, become integral components in delivering sophisticated, effective, and often life-enhancing solutions for a range of medical conditions.

Restraint:

High cost

The intricate research, development, and manufacturing processes, coupled with the need for stringent regulatory approvals, contribute to elevated production costs. Consequently, these expenses are often transferred to healthcare providers and, ultimately, patients, making implantable solutions financially burdensome. This high economic barrier limits the accessibility of medical implants, particularly in regions with constrained healthcare budgets, and may deter patients from pursuing these advanced treatment options. However, the cost factor exacerbates existing healthcare disparities, as individuals with limited financial means may face challenges in accessing cutting-edge implantable devices.

Opportunity:

Patient preference for implantable solutions

Patients are opting for implantable devices over traditional treatment modalities due to the perceived advantages they offer in terms of improved quality of life and long-term therapeutic benefits. Patients appreciate the potential for enhanced functionality and mobility that many implants provide, whether it is artificial joints for orthopedic conditions or neurostimulators for chronic pain management. Additionally, the growing acceptance of cosmetic implants, such as breast implants or dental prosthetics, reflects a broader societal shift towards embracing medical interventions that contribute to overall well-being and self-esteem.

Threat:

Risk of complications and failures

Patients and healthcare providers alike are often cautious about the potential adverse outcomes associated with implant procedures, ranging from device malfunctions to post-operative complications. Concerns about the safety and efficacy of medical implants can lead to hesitancy among both patients and healthcare professionals, thereby impeding the widespread adoption of these technologies. However, instances of device failures or complications can not only result in harm to patients but may also trigger legal and regulatory scrutiny, further dampening market.

Covid-19 Impact:

The immediate disruption caused by the global health crisis led to elective surgeries being postponed or canceled, affecting the demand for various medical implants. Hospitals and healthcare facilities shifted their focus and resources towards managing the surge in Covid-19 cases, diverting attention from non-urgent procedures. However, supply chain disruptions, restrictions on movement, and manufacturing slowdowns also hampered the production and distribution of medical implants.

The orthopedic implants segment is expected to be the largest during the forecast period

Due to the rising incidence of orthopedic conditions such as osteoarthritis, fractures, and musculoskeletal disorders, coupled with an aging global population, Orthopedic Implants segment is expected to hold the largest share over the projection period. As individuals seek enhanced mobility and improved quality of life, the demand for orthopedic implants, including joint replacements and spinal implants, has surged. Furthermore, the increasing trend towards minimally invasive surgical procedures has further fueled the demand for orthopedic implants, as these procedures often involve shorter recovery times and reduced post-operative complications.

The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period

Due to a shift in healthcare delivery by providing a more cost-effective, efficient, and patient-centric alternative to traditional hospital settings, Ambulatory Surgical Centers segment is poised to witness lucrative growth during the extrapolated period. Patients increasingly prefer ASCs for their convenience, quicker turnaround times, and lower infection risks compared to traditional hospitals. The demand for medical implants in ASCs is further fueled by the evolving landscape of healthcare, emphasizing personalized and specialized care.

Region with largest share:

Owing to a combination of advanced healthcare infrastructure and a rapidly aging population, North America commanded the largest share of the market throughout the extrapolated period. The country's well-established healthcare system, coupled with a favorable reimbursement landscape, encourages the adoption of cutting-edge implant technologies. Moreover, strategic collaborations between healthcare providers, manufacturers, and regulatory bodies facilitate efficient approval processes, ensuring timely market entry for new and improved medical implants.

Region with highest CAGR:

Asia Pacific region is estimated to witness profitable growth throughout the forecast period. Rapid economic development and a growing focus on technological advancements contribute to the region's prominence. In particular, the rising middle-class population, coupled with improved healthcare awareness, has led to an escalating demand for medical implants across various therapeutic areas. Regulatory bodies in countries such as China, India, and Japan are actively working to streamline approval processes, ensuring that innovative and safe medical implants enter the market efficiently.

Key players in the market

Some of the key players in Medical Implant market include 3M Company, Abbott Laboratories, Biotronik, Inc, Boston Scientific Corporation, Institut Straumann AG, Johnson & Johnson Medical GmbH, Livanova Plc, Medtronic plc, Novartis International AG, Smith & Nephew plc and Stryker Corporation.

Key Developments:

In March 2023, Miach Orthopaedics, Inc. entered a distribution agreement with Veteran's Health Medical Supply (VHMS). The agreement provides customers in 236 Department of Defense (DOD) and Department of Veterans Affairs (VA) healthcare facilities access to the Bridge Enhanced ACL Restoration (BEAR) Implant via the ECAT federal contract.

In February 2023, CurvaFix, Inc. launched its smaller-diameter, 7.5mm CurvaFix IM Implant, designed to simplify surgery and provide strong, stable fixation in small-boned patients.

In April 2022, 3M presently declared that it has gained the technology assets of LeanTec. The acquisition displays 3M's dedication to its "connected bodyshop". The LeanTec technology augments 3M™ RepairStack™ Performance Solutions.

In February 2022, Abbott declared the world's earliest patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i™ pivotal clinical investigation. The implant of Abbott's investigational Aveir™ dual-chamber leadless pacemaker depicts a considerable technological milestone for leadless pacing technology.

Products Covered:

  • Orthopedic Implants
  • Cardiovascular Implants
  • Ophthalmic Implants
  • Breast Implants
  • Dental Implants
  • Other Products

Materials Covered:

  • Ceramic Biomaterial
  • Natural Biomaterial
  • Polymers Biomaterial
  • Metallic Biomaterial
  • Other Materials

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Implant Market, By Product

  • 5.1 Introduction
  • 5.2 Orthopedic Implants
    • 5.2.1 Hip Orthopaedic Device
    • 5.2.2 Joint Reconstruction
    • 5.2.3 Knee Orthopedic Devices
    • 5.2.4 Spine Orthopedic Devices
    • 5.2.5 Other Orthopedic Implants
  • 5.3 Cardiovascular Implants
    • 5.3.1 Structural Cardiac Implants
    • 5.3.2 Pacing Devices
    • 5.3.3 Other Cardiovascular Implants
  • 5.4 Ophthalmic Implants
    • 5.4.1 Glaucoma Implants
    • 5.4.2 Intraocular Lens
    • 5.4.3 Other Ophthalmic Implants
  • 5.5 Breast Implants
  • 5.6 Dental Implants
  • 5.7 Other Products

6 Global Medical Implant Market, By Material

  • 6.1 Introduction
  • 6.2 Ceramic Biomaterial
  • 6.3 Natural Biomaterial
  • 6.4 Polymers Biomaterial
  • 6.5 Metallic Biomaterial
  • 6.6 Other Materials

7 Global Medical Implant Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Other End Users

8 Global Medical Implant Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M Company
  • 10.2 Abbott Laboratories
  • 10.3 Biotronik, Inc
  • 10.4 Boston Scientific Corporation
  • 10.5 Institut Straumann AG
  • 10.6 Johnson & Johnson Medical GmbH
  • 10.7 Livanova Plc
  • 10.8 Medtronic plc
  • 10.9 Novartis International AG
  • 10.10 Smith & Nephew plc
  • 10.11 Stryker Corporation

List of Tables

  • Table 1 Global Medical Implant Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Medical Implant Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Medical Implant Market Outlook, By Orthopedic Implants (2021-2030) ($MN)
  • Table 4 Global Medical Implant Market Outlook, By Hip Orthopaedic Device (2021-2030) ($MN)
  • Table 5 Global Medical Implant Market Outlook, By Joint Reconstruction (2021-2030) ($MN)
  • Table 6 Global Medical Implant Market Outlook, By Knee Orthopedic Devices (2021-2030) ($MN)
  • Table 7 Global Medical Implant Market Outlook, By Spine Orthopedic Devices (2021-2030) ($MN)
  • Table 8 Global Medical Implant Market Outlook, By Other Orthopedic Implants (2021-2030) ($MN)
  • Table 9 Global Medical Implant Market Outlook, By Cardiovascular Implants (2021-2030) ($MN)
  • Table 10 Global Medical Implant Market Outlook, By Structural Cardiac Implants (2021-2030) ($MN)
  • Table 11 Global Medical Implant Market Outlook, By Pacing Devices (2021-2030) ($MN)
  • Table 12 Global Medical Implant Market Outlook, By Other Cardiovascular Implants (2021-2030) ($MN)
  • Table 13 Global Medical Implant Market Outlook, By Ophthalmic Implants (2021-2030) ($MN)
  • Table 14 Global Medical Implant Market Outlook, By Glaucoma Implants (2021-2030) ($MN)
  • Table 15 Global Medical Implant Market Outlook, By Intraocular Lens (2021-2030) ($MN)
  • Table 16 Global Medical Implant Market Outlook, By Other Ophthalmic Implants (2021-2030) ($MN)
  • Table 17 Global Medical Implant Market Outlook, By Breast Implants (2021-2030) ($MN)
  • Table 18 Global Medical Implant Market Outlook, By Dental Implants (2021-2030) ($MN)
  • Table 19 Global Medical Implant Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 20 Global Medical Implant Market Outlook, By Material (2021-2030) ($MN)
  • Table 21 Global Medical Implant Market Outlook, By Ceramic Biomaterial (2021-2030) ($MN)
  • Table 22 Global Medical Implant Market Outlook, By Natural Biomaterial (2021-2030) ($MN)
  • Table 23 Global Medical Implant Market Outlook, By Polymers Biomaterial (2021-2030) ($MN)
  • Table 24 Global Medical Implant Market Outlook, By Metallic Biomaterial (2021-2030) ($MN)
  • Table 25 Global Medical Implant Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 26 Global Medical Implant Market Outlook, By End User (2021-2030) ($MN)
  • Table 27 Global Medical Implant Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 28 Global Medical Implant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 29 Global Medical Implant Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.